NasdaqGS - Delayed Quote USD

CEVA, Inc. (CEVA)

19.76 +0.07 (+0.36%)
At close: April 25 at 4:00 PM EDT
19.76 0.00 (0.00%)
After hours: April 25 at 4:20 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 6665
Avg. Estimate 0.030.040.310.5
Low Estimate 0.01-0.010.270.31
High Estimate 0.030.070.380.8
Year Ago EPS 0-0.020.10.31

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 6676
Avg. Estimate 23.13M24.37M103.02M114M
Low Estimate 22.9M24M102M111M
High Estimate 23.27M25.1M103.4M120M
Year Ago Sales 28.73M--97.42M103.02M
Sales Growth (year/est) -19.50%--5.70%10.70%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.120.070.040.06
EPS Actual 0-0.020.020.1
Difference -0.12-0.09-0.020.04
Surprise % -100.00%-128.60%-50.00%66.70%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.030.040.310.5
7 Days Ago 0.030.040.310.5
30 Days Ago 0.030.040.310.5
60 Days Ago 0.030.040.310.5
90 Days Ago 0.050.060.330.56

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD CEVAIndustrySectorS&P 500
Current Qtr. ------2.60%
Next Qtr. 300.00%----13.40%
Current Year 210.00%----5.20%
Next Year 61.30%----13.30%
Next 5 Years (per annum) -6.90%----11.11%
Past 5 Years (per annum) 3.95%------

Research Analysis

Analyst Price Targets

25.00
27.86 Average
19.76 Current
31.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Reiterates Rosenblatt: Buy to Buy 2/13/2024
Reiterates Rosenblatt: Buy to Buy 12/7/2023
Maintains Barclays: Overweight to Overweight 8/11/2023
Maintains Northland Capital Markets: Outperform to Outperform 8/10/2023
Downgrade Roth MKM: Buy to Neutral 8/10/2023
Maintains Rosenblatt: Buy to Buy 8/10/2023

Related Tickers